These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29592868)

  • 1. Ki67 proliferative index of the neuroendocrine component drives MANEC prognosis.
    Milione M; Maisonneuve P; Pellegrinelli A; Grillo F; Albarello L; Spaggiari P; Vanoli A; Tagliabue G; Pisa E; Messerini L; Centonze G; Inzani F; Scarpa A; Papotti M; Volante M; Sessa F; Fazio N; Pruneri G; Rindi G; Solcia E; La Rosa S; Capella C
    Endocr Relat Cancer; 2018 May; 25(5):583-593. PubMed ID: 29592868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity.
    Sahnane N; Furlan D; Monti M; Romualdi C; Vanoli A; Vicari E; Solcia E; Capella C; Sessa F; La Rosa S
    Endocr Relat Cancer; 2015 Feb; 22(1):35-45. PubMed ID: 25465415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive genetic features of gastric mixed adenoneuroendocrine carcinomas and pure neuroendocrine carcinomas.
    Koh J; Nam SK; Kwak Y; Kim G; Kim KK; Lee BC; Ahn SH; Park DJ; Kim HH; Park KU; Kim WH; Lee HS
    J Pathol; 2021 Jan; 253(1):94-105. PubMed ID: 32985687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal mixed adenoneuroendocrine carcinoma (MANEC): An immunohistochemistry study of 13 microsatellite stable cases.
    Gurzu S; Fetyko A; Bara T; Banias L; Butiurca VO; Bara T; Tudorache V; Jung I
    Pathol Res Pract; 2019 Dec; 215(12):152697. PubMed ID: 31704155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis.
    Milione M; Maisonneuve P; Grillo F; Mangogna A; Centonze G; Prinzi N; Pusceddu S; Garzone G; Cattaneo L; Busico A; Bossi P; Spaggiari P; Pellegrinelli A; Del Gobbo A; Ferrero S; Kankava K; Pruneri G; Rolli L; Roca E; Bercich L; Tironi A; Benvenuti MR; Gallazzi MS; Romano R; Berruti A; Pastorino U; Capella C
    Neuroendocrinology; 2021; 111(5):475-489. PubMed ID: 32365350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.
    Walter T; Tougeron D; Baudin E; Le Malicot K; Lecomte T; Malka D; Hentic O; Manfredi S; Bonnet I; Guimbaud R; Coriat R; Lepère C; Desauw C; Thirot-Bidault A; Dahan L; Roquin G; Aparicio T; Legoux JL; Lombard-Bohas C; Scoazec JY; Lepage C; Cadiot G;
    Eur J Cancer; 2017 Jul; 79():158-165. PubMed ID: 28501762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Clinicopathological Features of Biliary Neuroendocrine Carcinoma with Adenocarcinoma.
    Shiihara M; Higuchi R; Furukawa T; Yazawa T; Uemura S; Izumo W; Yamamoto M
    Dig Surg; 2021; 38(1):30-37. PubMed ID: 32570243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
    Lim SM; Kim H; Kang B; Kim HS; Rha SY; Noh SH; Hyung WJ; Cheong JH; Kim HI; Chung HC; Yun M; Cho A; Jung M
    Ann Nucl Med; 2016 May; 30(4):279-86. PubMed ID: 26837515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal and molecular pathway alterations in the neuroendocrine carcinoma and adenocarcinoma components of gastric mixed neuroendocrine-nonneuroendocrine neoplasm.
    Sun L; Zhang J; Wang C; Zhao S; Shao B; Guo Y; Liu Y; Sun Y
    Mod Pathol; 2020 Dec; 33(12):2602-2613. PubMed ID: 32461621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis.
    Centonze G; Maisonneuve P; Prinzi N; Pusceddu S; Albarello L; Pisa E; Barberis M; Vanoli A; Spaggiari P; Bossi P; Cattaneo L; Sabella G; Solcia E; La Rosa S; Grillo F; Tagliabue G; Scarpa A; Papotti M; Volante M; Mangogna A; Del Gobbo A; Ferrero S; Rolli L; Roca E; Bercich L; Benvenuti M; Messerini L; Inzani F; Pruneri G; Busico A; Perrone F; Tamborini E; Pellegrinelli A; Kankava K; Berruti A; Pastorino U; Fazio N; Sessa F; Capella C; Rindi G; Milione M
    Neuroendocrinology; 2023; 113(4):457-469. PubMed ID: 36417840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of insulinoma-associated protein 1 (INSM1) distinguishes colorectal mixed and pure neuroendocrine carcinomas from conventional adenocarcinomas with diffuse expression of synaptophysin.
    Litmeyer AS; Konukiewitz B; Kasajima A; Foersch S; Schicktanz F; Schmitt M; Kellers F; Grass A; Jank P; Lehman B; Gress TM; Rinke A; Bartsch DK; Denkert C; Weichert W; Klöppel G; Jesinghaus M
    J Pathol Clin Res; 2023 Nov; 9(6):498-509. PubMed ID: 37608427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
    Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
    J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma.
    Ali AS; Grönberg M; Federspiel B; Scoazec JY; Hjortland GO; Grønbæk H; Ladekarl M; Langer SW; Welin S; Vestermark LW; Arola J; Österlund P; Knigge U; Sorbye H; Grimelius L; Janson ET
    PLoS One; 2017; 12(11):e0187667. PubMed ID: 29112960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic outcome of mixed adenoneuroendocrine carcinoma (MANEC): A single center case series.
    Dulskas A; Pilvelis A
    Eur J Surg Oncol; 2020 Jan; 46(1):105-107. PubMed ID: 31444026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology.
    Crippa S; Partelli S; Belfiori G; Palucci M; Muffatti F; Adamenko O; Cardinali L; Doglioni C; Zamboni G; Falconi M
    World J Gastroenterol; 2016 Dec; 22(45):9944-9953. PubMed ID: 28018101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?
    Hijioka S; Hosoda W; Mizuno N; Hara K; Imaoka H; Bhatia V; Mekky MA; Tajika M; Tanaka T; Ishihara M; Yogi T; Tsutumi H; Fujiyoshi T; Sato T; Hieda N; Yoshida T; Okuno N; Shimizu Y; Yatabe Y; Niwa Y; Yamao K
    J Gastroenterol; 2015 May; 50(5):564-72. PubMed ID: 25142799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed adenoneuroendocrine carcinoma of gastrointestinal tract: report of two cases.
    Gurzu S; Kadar Z; Bara T; Bara T; Tamasi A; Azamfirei L; Jung I
    World J Gastroenterol; 2015 Jan; 21(4):1329-33. PubMed ID: 25632209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
    Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
    Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed adenoneuroendocrine carcinoma of the non-ampullary duodenum with mismatch repair deficiency: a rare case report.
    Nozawa Y; Ishida K; Maiko N; Takada-Owada A; Onozaki M; Takaoka M; Matsuyama K; Sakuraoka Y; Nakazato Y; Kubota K
    Med Mol Morphol; 2022 Sep; 55(3):258-266. PubMed ID: 35596001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric mixed adenoneuroendocrine carcinoma: correlation of histologic characteristics with prognosis.
    Nie L; Li M; He X; Feng A; Wu H; Fan X
    Ann Diagn Pathol; 2016 Dec; 25():48-53. PubMed ID: 27806846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.